C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/11 (2006.01) A61K 31/7125 (2006.01) C07H 21/00 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2380192
The invention relates to an oligonucleotide or one of its derivatives that is characterized by a sequence that corresponds to a nucleotide sequence that encodes a defined part of human eg5 or a mutated form thereof. The invention further relates to a method of producing said oligonucleotide and to its use.
La présente invention concerne un oligonucléotide ou un de ses dérivés, qui se caractérise en ce qu'il présente une séquence qui correspond à une séquence nucléotidique codant une partie définie d'une protéine eg5 humaine ou une forme mutée de celle-ci. Cette invention concerne également un procédé pour produire ces oligonucléotides, ainsi que leur utilisation.
Gothe Gislinde
Greiner Beate
Schwerdel Marc
Uhlmann Eugen
Unger Eberhard
Aventis Pharma Deutschland Gmbh
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Oligonucleotides for inhibiting the expression of human eg5 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oligonucleotides for inhibiting the expression of human eg5, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligonucleotides for inhibiting the expression of human eg5 will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1629180